Trade Summary

4 days ago, Daniell Richard, serving as EVP, Europe Commercial at Teva Pharmaceutical Industries Ltd (TEVA), sold 30,000 shares at $35.40 per share, for a total transaction value of $1,062,000.00. Following this transaction, Daniell Richard now holds 55,755 shares of TEVA.

This sale represents a 35.00% decrease in Daniell Richard's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, May 5, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, May 7, 2026, 2 days after the trade was made.

Teva Pharmaceutical Industries Ltd operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.